Top compounds associated with response to LRRC7


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.11 0.0008
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.1 0.001
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.097 0.001
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.003
Download CSV